Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 47 results.
User Information
Export Records
  1. 1.   Analytical characterization of ch14.18 A mouse-human chimeric disialoganglioside-specific therapeutic antibody
  2. Soman, G.; Kallarakal, A. T.; Michiel, D.; Yang, X. Y.; Saptharishi, N.; Jiang, H. G.; Giardina, S.; Gilly, J.; Mitra, G.
  3. Mabs. 2012, Jan-Feb; 4(1): 84-100.
  1. 2.   Targeted mass spectrometry approaches for protein biomarker verification
  2. Meng, Z. J.; Veenstra, T. D.
  3. Journal of Proteomics. 2011, Nov; 74(12): 2650-2659.
  1. 3.   A Reproducible and High-Throughput HPLC/MS Method To Separate Sarcosine from alpha- and beta-Alanine and To Quantify Sarcosine in Human Serum and Urine
  2. Meyer, T. E.; Fox, S. D.; Issaq, H. J.; Xu, X.; Chu, L. W.; Veenstra, T. D.; Hsing, A. W.
  3. Analytical Chemistry. 2011, Jul; 83(14): 5735-5740.
  1. 4.   A copper chelate of thiosemicarbazone NSC 689534 induces oxidative/ER stress and inhibits tumor growth in vitro and in vivo
  2. Hancock, C. N.; Stockwin, L. H.; Han, B. N.; Divelbiss, R. D.; Jun, J. H.; Malhotra, S. V.; Hollingshead, M. G.; Newton, D. L.
  3. Free Radical Biology and Medicine. 2011, Jan; 50(1): 110-121.
  1. 5.   Chromatographic methods for the quantification of free and chelated gadolinium species in MRI contrast agent formulations
  2. Clevel, D.; Long, S. E.; Sander, L. C.; Davis, W. C.; Murphy, K. E.; Case, R. J.; Rimmer, C. A.; Francini, L.; Patri, A. K.
  3. Analytical and Bioanalytical Chemistry. 2010, Dec; 398(7-8): 2987-2995.
  1. 6.   Approaching Solid Tumor Heterogeneity on a Cellular Basis by Tissue Proteomics Using Laser Capture Microdissection and Biological Mass Spectrometry
  2. Johann, D. J.; Rodriguez-Canales, J.; Mukherjee, S.; Prieto, D. A.; Hanson, J. C.; Emmert-Buck, M.; Blonder, J.
  3. Journal of Proteome Research. 2009 8(5): 2310-2318.
  1. 7.   Serum and plasma proteomics
  2. Issaq, H. J.; Xiao, Z.; Veenstra, T. D.
  3. Chemical Reviews. 2007, Aug; 107(8): 3601-3620.
  1. 8.   Analysis of fifteen estrogen metabolites using packed column supercritical fluid chromatography-mass spectrometry
  2. Xu, X.; Roman, J. M.; Veenstra, T. D.; Van Anda, J.; Ziegler, R. G.; Issaq, H. J.
  3. Analytical Chemistry. 2006, MAR 1; 78(5): 1553-1558.
  1. 9.   LC-MS in metabonomics: Optimization of experimental conditions for the analysis of metabolites in human urine
  2. Waybright, T. J.; Van, Q. N.; Muschik, G. M.; Conrads, T. P.; Veenstra, T. D.; Issaq, H. J.
  3. Journal of Liquid Chromatography & Related Technologies. 2006 29(17): 2475-2497.
  1. 10.   Comprehensive analysis of CDKN2A (p16(INK4A)/p14(ARF)) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma
  2. Laud, K.; Marian, C.; Avril, M. F.; Barrois, M.; Chompret, A.; Goldstein, A. M.; Tucker, M. A.; Clark, P. A.; Peters, G.; Chaudru, V.; Demenais, F.; Spatz, A.; Smith, M. W.; Lenoir, G. M.; Bressac-de Paillerets, B.; French Hereditary Melanoma Study, G.
  3. Journal of Medical Genetics. 2006, Jan; 43(1): 39-47.
  1. 11.   Inactivation of retroviruses with preservation of structural integrity by targeting the hydrophobic domain of the viral envelope
  2. Raviv, Y.; Viard, M.; Bess, J. W.; Chertova, E.; Blumenthal, R.
  3. Journal of Virology. 2005, OCT; 79(19): 12394-12400.
  1. 12.   Efficacy, plasma pharmacokinetics, and safety of icofungipen, an inhibitor of Candida isoleucyl-tRNA synthetase, in treatment of experimental disseminated candidiasis in persistently neutropenic rabbits
  2. Petraitiene, R.; Petraitis, V.; Kelaher, A. M.; Sarafandi, A. A.; Mickiene, D.; Groll, A. H.; Sein, T.; Bacher, J.; Walsh, T. J.
  3. Antimicrobial Agents and Chemotherapy. 2005, MAY; 49(5): 2084-2092.
  1. 13.   Multidimensional separation of peptides for effective proteomic analysis
  2. Issaq, H. J.; Chan, K. C.; Janini, G. M.; Conrads, T. P.; Veenstra, T. D.
  3. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences. 2005, MAR 5; 817(1): 35-47.
  1. 14.   Quantitative determination of antalarmin, a novel corticotropin-releasing hormone receptor-1 antagonist, in canine plasma by HPLC-MS
  2. Fox, S. D.; Roman, J. M.; Cizza, G.; Veenstra, T. D.; Issaq, H. J.
  3. Journal of Separation Science. 2005, MAR; 28(4): 332-336.
  1. 15.   Elimination of retroviral infectivity by N-ethylmaleimide with preservation of functional envelope glycoproteins
  2. Morcock, D. R.; Thomas, J. A.; Gagliardi, T. D.; Gorelick, R. J.; Roser, J. D.; Chertova, E. N.; Bess, J. W.; Ott, D. E.; Sattentau, Q. J.; Frank, I.; Pope, M.; Lifson, J. D.; Henderson, L. E.; Crise, B. J.
  3. Journal of Virology. 2005, FEB; 79(3): 1533-1542.
  1. 16.   Quantitative profiling of the detergent-resistant membrane proteome of Iota-b toxin induced Vero cells
  2. Blonder, J.; Hale, M. L.; Chan, K. C.; Yu, L. R.; Lucas, D. A.; Conrads, T. P.; Zhou, M.; Popoff, M. R.; Issaq, H. J.; Stiles, B. G.; Veenstra, T. D.
  3. Journal of Proteome Research. 2005, MAR-APR; 4(2): 523-531.
  1. 17.   Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague
  2. Powell, B. S.; Andrews, G. P.; Enama, J. T.; Jendrek, S.; Bolt, C.; Worsham, P.; Pullen, J. K.; Ribot, W.; Hines, H.; Smith, L.; Heath, D. G.; Adamovicz, J. J.
  3. Biotechnology Progress. 2005, SEP-OCT; 21(5): 1490-1510.
  1. 18.   A proteomic characterization of the plasma membrane of human epidermis by high-throughput mass spectrometry
  2. Blonder, J.; Terunuma, A.; Conrads, T. R.; Chan, K. C.; Yee, C.; Lucas, D. A.; Schaefer, C. F.; Yu, L. R.; Issaq, H. J.; Veenstra, T. D.; Vogel, J. C.
  3. Journal of Investigative Dermatology. 2004, OCT; 123(4): 691-699.
  1. 19.   Early onset hereditary papillary renal carcinoma: Germline missense mutations in the tyrosine kinase domain of the met proto-oncogene
  2. Schmidt, L. S.; Nickerson, M. L.; Angeloni, D.; Glenn, G. M.; Walther, M. M.; Albert, P. S.; Warren, M. B.; Choyke, P. L.; Torres-Cabala, C. A.; Merino, M. J.; Brunet, J.; Berez, V.; Borras, J.; Sesia, G.; Middelton, L.; Phillips, J. L.; Stolle, C.; Zbar, B.; Pautler, S. E.; Linehan, W. M.
  3. Journal of Urology. 2004, OCT; 172(4): 1256-1261.
  1. 20.   A detergent- and cyanogen bromide-free method for integral membrane proteomics: Application to Halobacterium purple membranes and the human epidermal membrane proteome
  2. Blonder, J.; Conrads, T. P.; Yu, L. R.; Terunuma, A.; Janini, G. M.; Issaq, H. J.; Vogel, J. C.; Veenstra, T. D.
  3. Proteomics. 2004 4(1): 31-45.
  1. 21.   Proteomic investigation of natural killer cell microsomes using gas-phase fractionation by mass spectrometry
  2. Blonder, J.; Rodriguez-Galan, M. C.; Lucas, D. A.; Young, H. A.; Issaq, H. J.; Veenstra, T. D.; Conrads, T. P.
  3. Biochimica Et Biophysica Acta-Proteins and Proteomics. 2004 1698(1): 87-95.
  1. 22.   Effect of a 4-month tea intervention on oxidative DNA damage among heavy smokers: Role of glutathione S-transferase genotypes
  2. Hakim, I. A.; Harris, R. B.; Chow, H. H. S.; Dean, M.; Brown, S.; Ali, I. U.
  3. Cancer Epidemiology Biomarkers & Prevention. 2004 13(2): 242-249.
  1. 23.   Characterization and analysis of thermal denaturation of antibodies by size exclusion high-performance liquid chromatography with quadruple detection
  2. Hartmann, W. K.; Saptharishi, N.; Yang, X. Y.; Mitra, G.; Soman, G.
  3. Analytical Biochemistry. 2004 325(2): 227-239.
  1. 24.   Direct ampholyte-free liquid-phase isoelectric peptide focusing: Application to the human serum proteome
  2. Xiao, Z.; Conrads, T. P.; Lucas, D. A.; Janini, G. M.; Schaefer, C. F.; Buetow, K. H.; Issaq, H. J.; Veenstra, T. D.
  3. Electrophoresis. 2004 25(1): 128-133.
  1. 25.   Quantitative proteomic analysis of inorganic phosphate-induced murine MC3T3-E1 osteoblast cells
  2. Conrads, K. A.; Yu, L. R.; Lucas, D. A.; Zhou, M.; Chan, K. C.; Simpson, K. A.; Schaefer, C. F.; Issaq, H. J.; Veenstra, T. D.; Beck, G. R.; Conrads, T. P.
  3. Electrophoresis. 2004 25(9): 1342-1352.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel